Emergent Health Statistics
Total Valuation
Emergent Health has a market cap or net worth of 384,256.
| Market Cap | 384,256 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Emergent Health has 426.95 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 426.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +457.42% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 10.68.
| Current Ratio | 0.94 |
| Quick Ratio | 0.74 |
| Debt / Equity | 10.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.28 |
Financial Efficiency
Return on equity (ROE) is -164.17% and return on invested capital (ROIC) is -36.11%.
| Return on Equity (ROE) | -164.17% |
| Return on Assets (ROA) | -35.62% |
| Return on Invested Capital (ROIC) | -36.11% |
| Return on Capital Employed (ROCE) | -630.97% |
| Revenue Per Employee | 17,081 |
| Profits Per Employee | -41,252 |
| Employee Count | 7 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.02, so Emergent Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 50.68 |
| Average Volume (20 Days) | 99,056 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Emergent Health had revenue of 119,567 and -288,764 in losses. Loss per share was -0.00.
| Revenue | 119,567 |
| Gross Profit | 79,477 |
| Operating Income | -199,571 |
| Pretax Income | -289,847 |
| Net Income | -288,764 |
| EBITDA | -179,571 |
| EBIT | -199,571 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 257,762 in cash and 337,671 in debt, giving a net cash position of -79,909 or -0.00 per share.
| Cash & Cash Equivalents | 257,762 |
| Total Debt | 337,671 |
| Net Cash | -79,909 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 31,629 |
| Book Value Per Share | -0.00 |
| Working Capital | -19,871 |
Cash Flow
| Operating Cash Flow | -161,628 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.47%, with operating and profit margins of -166.91% and -241.51%.
| Gross Margin | 66.47% |
| Operating Margin | -166.91% |
| Pretax Margin | -242.41% |
| Profit Margin | -241.51% |
| EBITDA Margin | -150.18% |
| EBIT Margin | -166.91% |
| FCF Margin | n/a |
Dividends & Yields
Emergent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -235.09% |
| Shareholder Yield | -235.09% |
| Earnings Yield | -75.15% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 31, 2009. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 31, 2009 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Emergent Health has an Altman Z-Score of -0.62. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.62 |
| Piotroski F-Score | n/a |